Does Aetna (CVS Health) Cover Finasteride?
A detailed breakdown of Aetna's finasteride coverage policies, formulary tiers, prior authorization criteria, step therapy requirements, and how to appeal a denial, with real dose and cost figures.
Finasteride
56 source-based articles maintained by the HealthRX.com Editorial Team.
56articles
7topic areas covered
Jul 10, 2025latest review
Finasteride library
Showing 56 of 56 clinical reviews.
Does Anthem (Elevance Health) Cover Finasteride?
A clinical and insurance guide to Anthem (Elevance Health) finasteride coverage, prior authorization criteria, step therapy requirements, formulary tier placement, and how to appeal a denial.
Does Cigna Cover Finasteride? Coverage, Formulary Tier, Prior Auth, and Appeals
A detailed guide to Cigna's finasteride coverage for hair loss and BPH: formulary tier, prior authorization requirements, step therapy, appeal strategies, and cost-saving options.
Does Kaiser Permanente Cover Finasteride?
A clinical guide to Kaiser Permanente's formulary status, prior authorization criteria, step therapy requirements, and appeal pathway for finasteride (1 mg and 5 mg) for hair loss and BPH.
Does State Medicaid Cover Finasteride?
A state-by-state guide to Medicaid coverage of finasteride for male pattern hair loss and BPH, including prior authorization criteria, step therapy requirements, appeal strategies, and cash-pay alternatives.
Does TRICARE Cover Finasteride? Coverage, Prior Auth, and Appeal Guide
Find out whether TRICARE covers finasteride for hair loss or BPH, what prior authorization looks like, which formulary tier it sits on, and how to appeal a denial step by step.
Does UnitedHealthcare Cover Finasteride?
A guide to UnitedHealthcare finasteride coverage, formulary tier, prior authorization criteria, step therapy requirements, and how to appeal a denial.
Finasteride Adult (30 to 49) Dosing: Evidence-Based Guide
Complete finasteride dosing guide for adults aged 30 to 49, covering 1 mg for hair loss and 5 mg for BPH, with trial data, safety monitoring, and clinical considerations.
Finasteride and Autoimmune Disease: What Clinicians and Patients Need to Know
A clinician-level review of finasteride's interactions with autoimmune conditions, including immune-mediated hair loss, post-finasteride syndrome debate, and prescribing considerations for patients with lupus, psoriasis, or other autoimmune diagnoses.
Finasteride Bone Health and Density Impact
A detailed clinical review of how finasteride affects bone mineral density, fracture risk, and skeletal health in men using the drug for AGA or BPH, with primary-literature citations and practical prescribing guidance.
Finasteride Cardiovascular Impact Long-Term: What the Evidence Actually Shows
A deep dive into finasteride's long-term cardiovascular effects, covering atherosclerosis, lipid shifts, blood pressure, sexual side effects, and what PCPT, PLESS, and newer cohort data say about heart risk.
Finasteride Cognitive Function Impact: What the Evidence Actually Shows
A clinician-level review of finasteride's effects on cognition, neurosteroid pathways, post-finasteride syndrome, and what current evidence says about memory, brain fog, and mood.
Finasteride Cost vs. Alternatives: A Full Clinical Comparison
How does finasteride cost compare to dutasteride, minoxidil, and other hair-loss and BPH treatments? A breakdown of mechanism, pricing, efficacy, and when to switch.
Finasteride Dosing for Adults Ages 50 to 64: A Clinical Guide
Evidence-based finasteride dosing for adults ages 50 to 64, covering AGA (1 mg) and BPH (5 mg) indications, polypharmacy interactions, cardiovascular considerations, and monitoring protocols.
Finasteride Dosing for Young Adults (Ages 18 to 29): What You Need to Know
A guide to finasteride dosing for men aged 18, 29, covering 1 mg AGA and 5 mg BPH protocols, fertility considerations, sexual side-effect data, and monitoring recommendations.
Finasteride Dosing in Hepatic Impairment
Evidence-based guide to finasteride use in patients with liver disease, including pharmacokinetic considerations, dose adjustments, and monitoring recommendations for prescribers.
Finasteride Dosing in Renal Impairment: What the Evidence Actually Shows
Finasteride requires no dose adjustment in renal impairment. This MD-reviewed guide covers the pharmacokinetic data, hepatic metabolism, and clinical considerations for prescribing finasteride to patients with kidney disease.
Finasteride Evolution: What's Next After the 1mg Pill
Finasteride evolution traces 25+ years from oral 1mg to new topical and nanoparticle formulas cutting systemic absorption up to 95% while maintaining DHT reduction.
Finasteride Food & Supplement Interactions
Finasteride can be taken with or without food. Compare supplement evidence, biotin lab interference, and claims not established in finasteride studies.
Finasteride Geriatric (65+) Dosing: What Older Adults Need to Know
Evidence-based guide to finasteride dosing in adults 65 and older, covering BPH and hair loss indications, renal considerations, drug interactions, and deprescribing.
Finasteride Geriatric (65+) Monitoring: Lab Tests, Safety Checks, and Clinical Oversight
Evidence-based monitoring guide for finasteride use in adults 65 and older, covering PSA adjustments, renal function, sexual side effects, falls risk, and deprescribing timelines.
Finasteride Hair and Skin Changes: What the Clinical Evidence Actually Shows
A guide to how finasteride changes hair density, skin oiliness, and scalp health. Includes real trial data, doses, timelines, and safety context.
Finasteride Half-Life: 5 to 6 Hours (What It Means)
Finasteride's terminal half-life is 5 to 6 hours in men 18-60 (8+ hours over 70), but its effect on DHT lasts much longer due to irreversible enzyme binding.
Finasteride History and Development: From Prostate Drug to Hair Loss Treatment
A detailed timeline of finasteride's discovery, FDA approvals, mechanism of action, and clinical development from Merck's 5-alpha reductase research through modern generic availability.
Finasteride in Special Populations: Transplant, HIV, Hepatic Impairment, and Beyond
Evidence-based guide to finasteride use in transplant recipients, people living with HIV, patients with liver disease, and other special populations. Covers drug interactions, dose adjustments, and monitoring.
Finasteride Liver Function Impact: What the Evidence Actually Shows
A clinical deep-dive into how finasteride affects liver enzymes, hepatotoxicity risk, and what monitoring is needed for men using 1 mg or 5 mg daily.
Finasteride Manufacturing, Supply & Shortage History
A clinician-level review of how finasteride is made, which manufacturers supply it, what caused past shortages, and what patients and prescribers should know about supply risks today.
Finasteride Mechanism of Action: The Full Enzymatic Pathway Explained
A physician-level explanation of how finasteride inhibits 5-alpha reductase type II, reduces scalp DHT, and reverses miniaturization in androgenetic alopecia and BPH.
Finasteride Microdosing Protocols: What the Evidence Actually Shows
A deep dive into finasteride microdosing for androgenetic alopecia, covering dose-response pharmacology, DHT suppression at sub-milligram doses, side-effect considerations, and what a clinician conversation about off-label dosing should cover.
Finasteride Missed-Dose Protocol: What to Do When You Skip a Pill
Missed a finasteride dose? Don't double up. Take it the same day if you remember; if your next dose is close, skip it and resume your regular schedule.
Finasteride Monitoring for Adults 30 to 49: Labs, Timelines, and What to Track
A clinical guide to monitoring finasteride in adults aged 30 to 49, covering baseline labs, PSA adjustments, hormonal panels, sexual function screening, and follow-up schedules for both AGA and BPH indications.
Finasteride Monitoring for Older Adults (50 to 64): Lab Tests, PSA Adjustments, and Safety Checks
A clinical guide to monitoring finasteride in adults aged 50 to 64, covering PSA correction, baseline labs, sexual side-effect tracking, polypharmacy review, and evidence-based timelines.
Finasteride Monitoring Schedule: Labs & Exams Your Doctor Should Order
Evidence-based finasteride monitoring schedule covering baseline labs, PSA adjustments, liver function, hormones, and follow-up exams for men on 1 mg or 5 mg finasteride.
Finasteride Muscle Preservation Strategies: What the Evidence Actually Shows
A clinical deep-dive into how finasteride affects muscle mass, strength, and recovery, and the specific strategies men on finasteride can use to protect their gains, prepared by the HealthRX.com Editorial Team.
Finasteride Off-Label Uses: Evidence Levels for Each Indication
A guide to finasteride's off-label applications beyond BPH and male pattern hair loss, with trial data and evidence grading for each use.
Finasteride Overdose and Accidental Excess Dose: What Clinicians and Patients Need to Know
A guide to finasteride overdose, accidental excess dosing, mechanism of action, and 5-alpha reductase inhibition, with FDA-cited evidence and toxicology data.
Finasteride Patent History and Generic Timeline: Everything Clinicians and Patients Need to Know
A comprehensive guide to finasteride's mechanism of action, patent expiration, generic availability, and clinical evidence for AGA and BPH.
Finasteride Pharmacogenomics & Genetic Variability: A Complete Clinical Guide
How SRD5A1/SRD5A2 polymorphisms, CYP3A4 variants, and androgen-receptor genetics shape finasteride response, adverse-effect risk, and dosing decisions, with PubMed-cited evidence.
Finasteride Pregnancy & Lactation Safety: What Patients and Partners Must Know
Finasteride family planning: distinguish maternal use, tablet contact, semen exposure, fertility studies, breastfeeding and medication-pause decisions.
Finasteride Real-World Evidence: What Registries and RWE Studies Actually Show
A clinician-grade review of finasteride real-world evidence from patient registries, electronic health record studies, and post-marketing surveillance for hair loss and BPH.
Finasteride Rebound Effects When Stopping: What the Evidence Actually Shows
A guide to what happens when you stop finasteride, including hair loss rebound timelines, hormonal changes, post-finasteride syndrome, and how to minimize shedding after discontinuation.
Finasteride Regulatory Status: US, EU, Canada, UK Approval History and Current Standing
A clinician-grade overview of finasteride's regulatory approvals across the US, EU, Canada, and UK, including approved indications, dose forms, generic availability, and post-market safety actions.
Finasteride Renal Protection or Renal Risk: What the Evidence Actually Shows
A comprehensive analysis of finasteride's effects on kidney function, including BPH-related obstructive nephropathy, direct renal toxicity data, and clinical guidance for patients with CKD.
Finasteride Safety for Adults (30 to 49): What the Evidence Actually Shows
A clinical review of finasteride safety data for men aged 30 to 49, covering sexual side effects, mental health signals, post-finasteride syndrome, liver and cardiovascular markers, and monitoring protocols.
Finasteride Safety for Adults Ages 50 to 64: What the Evidence Shows
A guide to finasteride safety in adults aged 50, 64, covering cardiovascular risk, drug interactions, sexual side effects, prostate cancer screening, and dosing for AGA and BPH.
Finasteride Safety in Adults 65 and Older: Risks, Monitoring, and Deprescribing
Evidence-based review of finasteride safety in geriatric patients (65+), covering sexual side effects, PSA masking, cognitive concerns, falls risk, polypharmacy, and when to consider stopping.
Finasteride Safety in Young Adults (18 to 29): What the Evidence Actually Shows
Finasteride at ages 18-29: compare actual sexual-effect, mood and fertility studies, distinguish 1 mg from 5 mg evidence, and assess topical alternatives.
Finasteride Safety Signals and FDA Actions: What the Evidence Shows
Finasteride side effects: trials showed sexual problems in 3.8% of users vs 2.1% on placebo. FDA labels now add warnings for depression and suicidality.
Finasteride Self-Injection Technique, Mechanism, and Clinical Use Guide
A deep dive into how finasteride works, its 5-alpha-reductase inhibition mechanism, oral dosing, and why injectable forms are not used in standard practice. Includes trial data, dosing tables, and clinical FAQs.
Finasteride Sleep Architecture Impact: What the Evidence Actually Shows
Finasteride alters neurosteroid synthesis, which may disrupt sleep architecture in a subset of users. This clinical review covers the mechanism, the evidence, and what prescribers and patients should monitor.
Finasteride Storage: Separate the Bottle Label, Expiration and Compounded Formula
Read finasteride storage instructions correctly: distinguish the exact tablet label, printed expiration, split tablets and compounded topical BUD.
Finasteride Switching Protocols: How to Transition From or To Other Drugs in Class
Evidence-based protocols for switching between finasteride, dutasteride, minoxidil, and combination therapies for hair loss (AGA) and BPH, with MD-level clinical guidance and PubMed-cited sources.
Finasteride Young Adult (18 to 29) Monitoring: Lab Schedule, Side-Effect Tracking, and When to Stop
Evidence-based monitoring protocol for finasteride in young adults aged 18 to 29, covering baseline labs, follow-up intervals, sexual side effects, mental health screening, and fertility planning.
Finasteride: What to Expect Week by Week in Your First Month
A week-by-week breakdown of what finasteride does in month one, covering DHT suppression timelines, shedding phases, side-effect windows, and what lab or photo benchmarks to track before results appear.
How to Safely Stop Finasteride: An Evidence-Based Discontinuation Guide
How stopping finasteride differs for 1 mg hair loss and 5 mg BPH, including taper evidence, loss of benefit, PSA context, and current safety warnings.
Is Finasteride a Blood Thinner? No, Here's Its Drug Profile
Finasteride is not a blood thinner. It has no FDA-listed drug interactions, though it does cut PSA levels by about 50% and pairs safely with alpha-blockers.